WHO ICTRP trial

ROLO The Renoprotective value of Leukodepletion in Heart Valve surgery

ISRCTN42121335 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN42121335
Public title ROLO The Renoprotective value of Leukodepletion in Heart Valve surgery
Scientific title The Renoprotective value of Leukodepletion in Heart Valve surgery: an external feasibility randomised controlled trial
Primary sponsor Blackpool, Fylde and Wyre Hospitals NHS Trust (UK)
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries United Kingdom
Conditions Topic: Cardiovascular; Subtopic: Cardiovascular (all Subtopics); Disease: Cardiovascular Circulatory System
Interventions Current interventions as of 18/05/2017: Eligible patients are randomised either to a LG6B leukocyte-depleting filter, or a standard 40µm filter into the arterial line of the extracorporeal circuit downstream from the CPB pump. All patients…
Registration date Feb 18, 2014
Target size 54
Secondary IDs 15826
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations